Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre

Intern Med J. 2022 Jul;52(7):1286-1287. doi: 10.1111/imj.15851.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Humans
  • Lymphoma, Mantle-Cell* / diagnosis
  • Lymphoma, Mantle-Cell* / genetics
  • Mutation
  • Prognosis
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53